| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net income/(loss) | |||||||||
-6,327 | -5,201 | 5,261 | -149 | 3,204 | -2,473 | -560 | 435 | 3,779 | 531 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | |||||||||
Stock-based compensation | |||||||||
572 | 939 | 932 | 775 | 750 | 515 | 461 | 234 | 290 | 172 |
(Gain) on sale of buildings | |||||||||
- | - | - | - | - | - | 887 | - | - | - |
(Gain)/loss on sale of buildings | |||||||||
- | - | - | - | - | - | - | -693 | - | - |
(Gain) on sale of other fixed assets | |||||||||
- | - | - | - | - | 8 | -16 | 3 | - | - |
Depreciation and amortization | |||||||||
1,042 | 1,141 | 867 | 813 | 826 | 797 | 646 | 515 | 597 | 588 |
Deferred income tax (benefit)/expense | |||||||||
1,425 | -495 | 831 | -435 | 1,633 | -1,483 | -1,396 | -178 | 433 | 76 |
Recovery of contingent earnout | |||||||||
-200 | - | - | - | - | - | - | - | - | - |
Provision for inventory obsolescence | |||||||||
- | - | 606 | - | - | - | - | - | - | - |
Deferred revenue | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Provision for bad debts | |||||||||
- | - | 2 | -16 | -30 | -58 | 75 | 6 | 6 | -37 |
(Increase)/decrease in operating assets | |||||||||
Accounts receivable | |||||||||
-1,519 | 2,006 | 1,453 | -2,500 | -3,402 | 3,521 | -1,556 | 858 | 760 | 741 |
Contract assets | |||||||||
-844 | -7,039 | 5,800 | - | - | - | - | - | - | - |
Costs and estimated earnings in excess of billings on contracts in progress | |||||||||
- | - | - | -2,038 | 2,136 | 920 | -1,152 | -680 | 1,752 | -1,049 |
Inventories | |||||||||
-152 | -1,103 | 260 | 290 | -1,855 | 344 | 1,754 | -464 | -760 | 211 |
Other current assets | |||||||||
- | - | -68 | 68 | -27 | -51 | 53 | 41 | 14 | -77 |
Purchase of building | |||||||||
- | - | 14,000 | 0 | - | - | - | - | - | - |
Purchase of MesoScribe Technologies | |||||||||
- | - | 419 | 500 | - | - | - | - | - | - |
Other assets | |||||||||
-125 | 552 | 10 | -1 | - | - | - | - | - | - |
Increase/(decrease) in operating liabilities | |||||||||
Accounts payable | |||||||||
-177 | -461 | 431 | 435 | -1,374 | 1,214 | -419 | 106 | 495 | -232 |
Accrued expenses | |||||||||
315 | -1,235 | 795 | -1,503 | 148 | 1,490 | 450 | -271 | - | 261 |
Current maturities of long term debt | |||||||||
- | - | - | -280 | -140 | - | - | - | - | - |
Contract liabilities | |||||||||
309 | 70 | -4,796 | - | - | - | - | - | - | - |
Billings in excess of costs and estimated earningson contracts in progress | |||||||||
- | - | - | 5,262 | -1,328 | 1,075 | -223 | -1,211 | -636 | 2,323 |
Accrued litigation settlement | |||||||||
- | - | - | - | -4,925 | 4,925 | - | - | - | - |
Deferred revenue | |||||||||
969 | 167 | 134 | -230 | -181 | 284 | -130 | -754 | 989 | -51 |
Total adjustments | |||||||||
6,898 | 5,710 | -7,640 | 9,001 | -1,471 | 4,018 | -507 | -617 | 408 | 3,275 |
Net cash (used in) provided by operating activities | |||||||||
570 | 509 | -2,379 | 8,852 | 1,733 | 1,545 | -1,067 | -182 | 4,187 | 3,807 |
Cash flows from investing activities: | |||||||||
Release of restricted cash | |||||||||
- | - | - | -200 | -200 | -400 | - | -200 | 1,000 | - |
Capital expenditures | |||||||||
2,688 | 2,537 | 889 | 112 | 248 | 617 | 2,071 | 11,796 | 204 | 373 |
Purchase of assets Tantaline A/S | |||||||||
- | - | 419 | 500 | 0 | - | - | - | - | - |
Deposits | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Proceeds from sale of building | |||||||||
- | - | - | - | - | - | 3,619 | - | - | - |
Proceeds from sale of other fixed assets | |||||||||
- | - | - | - | - | 8 | - | - | - | - |
Deposits | |||||||||
- | - | - | - | - | -1 | -6 | -322 | 360 | - |
Net cash used in investing activities | |||||||||
-2,688 | -2,537 | -15,320 | -410 | -47 | -208 | 1,555 | -9,670 | -1,564 | -373 |
Net proceeds from issuance of common stock (Note 11) | |||||||||
- | - | - | - | - | - | - | - | 9,387 | - |
Net proceeds from stock options exercised | |||||||||
- | - | 146 | 462 | - | 102 | 75 | 286 | 473 | 63 |
Proceeds from mortgage payable | |||||||||
- | - | 10,387 | 0 | - | - | - | 6,000 | 2,100 | - |
Payments of long-term debt | |||||||||
657 | 743 | 300 | 300 | 580 | 720 | 3,037 | 848 | 2,697 | 368 |
Net cash used in financing activities | |||||||||
-657 | -743 | 10,233 | 162 | -580 | -617 | -2,961 | 5,437 | 9,264 | -304 |
Net decrease in cash and cash equivalents | |||||||||
-2,775 | -2,771 | -7,466 | 8,603 | 1,106 | 719 | -2,473 | -4,415 | 11,887 | 3,129 |
Supplemental disclosure of cash flow information: | |||||||||
Income taxes paid | |||||||||
2 | 472 | 601 | 101 | 427 | 0 | 0 | 451 | 813 | 40 |
Interest paid | |||||||||
365 | 463 | 71 | 79 | - | - | - | - | - | - |
Capitalization of right to use Asset | |||||||||
84 | - | - | - | - | - | - | - | - | - |
Interest paid | |||||||||
- | - | - | - | 92 | 109 | 163 | 204 | 182 | 226 |